To monitor a patient for the possibility of reactive bronchospasm during aerosol drug therapy, what should you do?
I. Measure pre- and post-peak flow and/or percentage forced expiratory volume in 1 second (%FEV1).
II. Auscultate for adventitious breath sounds.
III. Carefully observe the patient’s response.
IV. Communicate with the patient during therapy.

Question

To monitor a patient for the possibility of reactive bronchospasm during aerosol drug therapy, what should you do?
I.	Measure pre- and post-peak flow and/or percentage forced expiratory volume in 1 second (%FEV1).
II.	Auscultate for adventitious breath sounds.
III.	Carefully observe the patient’s response.
IV.	Communicate with the patient during therapy.

Quizplus · Accepted Answer

All the options listed are appropriate measures to monitor a patient for the possibility of reactive bronchospasm during aerosol drug therapy. Measuring pre- and post-therapy peak flow or %FEV1 can provide objective data on lung function. Auscultation can help detect changes in breath sounds that may indicate bronchospasm. Observing the patient's response and communicating with them are essential for assessing subjective symptoms and ensuring patient safety.

To Monitor a Patient for the Possibility of Reactive Bronchospasm